Background: Apoptosis is an active cell death process mediated by caspases activation, in which different extrinsic or intrinsic signalling pathways result in direct activation of effector caspases. Caspase-3 is considered to be the most important of the executioner caspases, which cause the morphological and biochemical changes detected in apoptotic cells. Different bacterial and virus pathogens have developed different strategies to survive inside the host and overcome natural protections, one of them is inducing apoptotic death in infected cells. We have demonstrated previously that Piscirickettsia salmonis activates this process in monocytes/macrophages from salmonid RTS11 cell line both by morphological and caspase detection assays; nevertheless, recognition of caspase activation by western blot was impossible since most of the commercially available antibodies for mammalian caspases are not cross-reacting. Results: We have generated a monospecific polyclonal antibody directed to an epitope region of salmonid caspase-3; the selected epitope present high homology with caspase-3 from others teleost species and includes the active site of the enzyme. The peptide was designed using bioinformatics tools and was chemically synthesized using the Fmoc strategy, analysed by RP-HPLC, its molecular weight confirmed by mass spectrometry and its structure analyzed by circular dichroism. The synthetic peptide was immunized and antibodies from ascitic fluid were enriched for immunoglobulins using caprylic acid and then purified by activated affinity columns. The anti-peptide activity of purified antibodies was verified by ELISA, and the ability of the anti-peptide to recognize salmonid caspase-3 activation was demonstrated with the molecule in P. salmonis RTS11 infected cells by western blotting, ELISA and immunocytochemistry. Conclusions: This is the first antibody available for a fish caspase, specifically for trout caspase-3, whose applications were validated by different immunological assays.
INTRODUCTION
Cell death may occur by two opposite modes: programmed or unregulated form; the former process includes apoptosis, autophagy, paraptosis, piroptosis or necroptosis and the latter refers to necrosis (Fink and Cookson, 2005; Elmore, 2007; Vandenabeele et al. 2010) . Apoptosis is an evolutionarily conserved and genetically controlled multistep process of cell death in response to a wide variety of stimuli that can be signalled from the external environment or from inside the cell. The mechanism of programmed cell death progresses through a series of morphological changes mediated by the activation of specific cystein proteases named caspases (Fan et al. 2005) . Once activated, caspases selectively cleave many specific target proteins and thereby bring about the characteristic apoptotic morphology. There are two major apoptotic pathways through which these proteases can be activated: the death-receptor and the mitochondrial pathways, which induce initiator caspases 8 and 9, respectively (Elmore, 2007) . Signal transduction pathways send the message to the cell death effector caspases, which include caspase-3, the most important terminal caspase essential for execution of apoptosis (Hengartner, 2000; Gupta, 2003; Elmore, 2007) .
Caspases are aspartate-specific cystein proteases with a conserved QACXG motif (X can be R, Q or D). They are all expressed as enzymatically inert zymogens (30 to 50 kD) composed of three domains, an N-terminal prodomain, and one large (~20 kD) and one small subunit (~10 kD). In contrast to the strong conservation in the large and small subunits, the size and sequence of the prodomains show little similarity over different species. Activation involves proteolytic processing between domains, followed by association of the large and small subunits to form a heterodimer with two QACXG active sites (Shi, 2002; Fan et al. 2005 ).
Apoptosis and caspases have been widely investigated in many animal species including Drosophila, mammals, and humans; however, information on both the apoptotic process and the enzymes involved are scarce in fish. The caspase-3 gene has been sequenced and characterized in zebrafish (Danio rerio) (Yabu et al. 2001; Chakraborty et al. 2006; Eimon and Ashkenazi, 2010) , sea bass (Dicentrarchus labrax L.) (Reis et al. 2007 ) and gudgeon (Gobio gobio) (Nadzialek et al. 2010) , though sequences are available in the databases for other teleostei species, such as trout (Oncorhynchus mykiss), salmon (Salmo salar), seabream (Sparus auratus), Japanese medaka (Oryzias latipes), channel catfish (Ictalurus punctatus), mandarin fish (Siniperca chuatsi) and tiger puffer (Takifugu rubripes).
In a previous study we demonstrated that Piscirickettsia salmonis, which is the etiologic agent of a systemic infection named salmonid rickettsial septicaemia (SRS), disease that affects all cultured salmon fish species and salmon production in Chile, induces apoptosis in macrophages and monocytelike cells from the rainbow trout cell line RTS11, as shown by the morphological and biochemical features of the apoptosis (Rojas et al. 2010) . Numerous experiments with a variety of pathogens demonstrate that apoptosis of professional phagocytes is a common event in pathogenesis and plays a pivotal role in the initiation of the infection and the survival of the pathogens, resulting in a decrease in the effectiveness of the immune response and a further spreading of the pathogens to other tissues (Gao and Kwaik, 2000; Navarre and Zychlinsky, 2000; Hasnain et al. 2003; Lai and Sjöstedt, 2003; DeLeo, 2004; Zhang and Bliska, 2005; Carrero and Unanue, 2006; Miyairi and Byrne, 2006) . More recently, studies by Soto et al. 2010 demonstrated apoptosis in head kidney macrophages from tilapia (Oreochromis spp.) infected with Francisella asiatica, which caused substantial mortality in this and other important warm and cold water species.
Compared to other vertebrates, fish caspase-3 share similarities in sequence organization, conserved pentapeptide active-site QACRG and substrate specificity; nevertheless, phylogenetic analysis shows that this corresponds to a divergent evolving group (Yabu et al. 2001; Reis el al. 2007) . There are few reports where fish caspase-3 has been detected with commercially available antibodies for mammals; the activation of this enzyme has been described in Chinook salmon derived CHSE-214 cells infected with the infectious pancreatic virus (IPNV) using an anti-mouse caspase-3 monoclonal antibody (Amersham, Piscataway, NJ, USA) (Chen et al. 2010) . In a transgenic zebrafish cell line incubated with metrodinazole, an anti-activated caspase-3 for human and mouse (BD Biosciences 559565) detected mainly pro-caspase and active-caspase-3 but also other bands with less intensity in a western blotting assay (Chen et al. 2011 ).
We have previously assayed several commercial antibodies for detection of active caspase-3 in P. salmonis infected RTS11 cells by western blot. Our analysis with polyclonal antibodies for human antiactivated caspase-3 and anti-subunits and precursor of caspase-3 (BD Pharmingen 551150, 552785), and also with polyclonal antibody for human caspase-3 (Santa Cruz Biotechnology, Inc sc-7148), resulted in nonspecific recognition of multiple bands of different molecular weights.
In this work we present a monospecific polyclonal antibody designed to recognize an epitope which includes the active site from salmonid caspase-3. The specificity and versatility of the antibody was shown by dot blot, ELISA, western blot and immunocytochemistry and its effectiveness was validated in rainbow trout RTS11 cells induced to apoptosis by P. salmonis. This antibody constitutes a valuable tool to study the molecular mechanisms that regulate cell suicide in fundamental issues such as embryogenesis, tissue homeostasis, disease development and cell-pathogen interactions in salmonids where commercial antibodies to other species usually give very poor results.
MATERIALS AND METHODS

Peptide design
Peptides were designed taking into account the caspase-3 homologous sequence of Oncorhynchus mykiss and Salmo salar available at the time (GenBank CBY85134 and NM001139921). An alignment with ClustalW (Larkin et al. 2007 ) was performed with different fish caspase-3 sequences incorporating the conserved motif QACRG included in the active site. To define the best antigenic epitope, the method of Kolaskar and Tongaonkar (Kolaskar and Tongaonkar, 1990 ) was used in the bioinformatics server from the Immunomedicine group at the Universidad Complutense de Madrid, Spain (http://imed.med.ucm.es/Tools/antigenic.pl). Protscale (Gasteiger et al. 2005 ) through the Expasy server (Gasteiger et al. 2003 ) was used to analyze the physicochemical behaviour of the antigenic sequences and identify regions of high hydrophilicity and mean flexibility. The antigenic region in the entire molecule was located using a homology model (pdb 2J30) from the automatic modelling mode in the workspace of the Swissmodel server (Arnold et al. 2006) .
Peptide microanalysis and synthesis
Peptides were chemically synthesized using a solid phase multiple peptide system (Houghten, 1985) with N-fluorenylmethoxycarbonyl (Fmoc) protected amino acids (Iris and Rink resin 0.65 meq/g). Peptides were cleaved by TFA/TIS/H 2 0 (95%/2.5%/2.5%) (Novabiochem, USA) and purified by reverse-phase HPLC (RP-HPLC) to purity to >95% using a Waters C18 column (0-70% gradient of aqueous acetonitrile); the elution was monitored by UV absorption at 210 nm. Peptides were lyophilized on a Jasco Instrument (Pump PU-2089, Detector UV-2075, Autosampler AS-2055 Jasco, Japan). Mass spectrometry was performed by matrix-assisted laser desorption ionization time of flight on a MALDI-TOF Microflex instrument (Bruker Daltonics INC. MA-USA). Additionally, CD spectra were recorded at room temperature on a Jasco J-810 spectropolarimeter (Jasco, Japan) using a Peltier system PFD-425S. Solutions of the peptide at 0.1 mg/ml in different percentages of 2,2,2-trifluoroethanol (TFE) were used (Roccatano et al. 2002) . The recorded spectra are the average of three consecutive scans from 190 to 250 nm using a 1 mm quartz cell. The parameters used were: scan speed 100 nm*min -1 data pitch 0.2 nm, 2 sec response, 1 nm band width and 3 scans.
Antibody production
To generate the antibodies, CF-1 mice obtained from the Institute of Public Health, Santiago, Chile, were immunized at day 0, 7, 14, 21 by intraperitoneal injection with 60 μg of the epitope peptides and FIS (a T helper cell activator) in 1:1 relation (Prieto et al. 1995) supplemented with 500 μl of Freunds complete adjuvant (Thermo Scientific Inc., USA). On day 6, 0.6 ml of pristane (2,6,10,14-tetramethylpentadecane) (Sigma-Aldrich, MO, USA.) was injected to induce ascitic tumour formation (Narvaez et al. 2010; Bethke et al. 2012) . From day 30, mice were anesthetized with a small dose of chloroform and drained with an 18G * 1½" needle (Nipro Corporation, Japan). Ascitic fluid was recovered in the supernatant after centrifugation at 300 g for 10 min and subsequently analyzed by dot blot.
Blot was performed in a 0.45 µm Nitrocellulose membrane (Thermo Scientific Inc., USA) seeding 2, 1 and 0.5 µg of the synthetic peptide and 1 µl of the ascitic fluid containing the anti-epitope of caspase-3 as a positive control. The membranes were blocked with 3% BSA in phosphate-buffered saline (PBSA) for 90 min at 37ºC; washed 5 times with PBS-Tween 0.05% (PBST) and incubated with 0.25 µg/µlof ascitic fluid anti-caspase-3 for 90 min at 37ºC. Following 3 washes the second anti-IgG mouse-HRP antibody (Thermo Scientific Inc., USA) at a ratio of 1:7,000 was added and incubated at 37ºC for 60 min. The membranes were revealed with DAB (3,3 diaminobenzidine, Sigma-Aldrich, MO, USA) and hydrogen peroxide in PBS (10 mg; 10 μl; 10 ml). As a control, we used another synthetic peptide which is not recognized by the anti-epitope of caspase-3.
Anti-caspase ascitic fluids were enriched for IgG by slowly adding 2 vol. of 60 mM sodium acetate (pH 4.0) and 0.4 vol. of caprylic acid. The supernatant was recovered after centrifugation at 10.000 x g for 10 min and IgG were purified by immunoaffinity chromatography using Cyanogen Bromide-Activated Sepharose 4B (Sigma-Aldrich, MO, USA). The IgG fraction was filtered through a 0.22 mm filter (Millipore Corporation, USA) and diluted ten times with phosphate buffered saline (PBS, pH 7.4). Then 0.2 g of gel was prepared with 1 ml of 1 mM HCl. The synthetic epitope (1 mg) was coupled with the prepared gel in a coupling buffer (0.1 M NaHCO3, 0.5 M NaCl pH 8.4). The unreacted active groups were blocked with 0.1 M Tris pH 8. Finally, the prepared mouse ascitic fluid was mixed with the Sepharose-coupled peptide. The mixture was rotated overnight at 4ºC, and afterwards the gel was washed alternating 0.1 M sodium acetate 0.5 M NaCl pH 4 and Tris HCl 0.1 M NaCl 0.5 M pH 8.3. It was then eluted with 100 mM glycine (pH 2.5) and the monospecific antibodies were collected in 1 M Tris (pH 8), labelled as anti-epitope of caspase-3 and stored at -20ºC.
Antibody quantification and validation
IgG concentration was quantified by ELISA (Corrales et al. 2009 ). Briefly, multiwell plates were incubated ON at 4ºC with different concentrations of the eluted antibody. After blocking for 2 hrs with 1% BSA in PBS, they were incubated with commercial anti-IgG peroxidase-conjugated antibodies. The plates were washed three times with PBST in JENCONS Millenium 1000 Automatic Microplate Washer, subsequently 100 μl per well 3,3,5-5-tetrametilbenzidine (TMB) single solution (Invitrogen, Paisley, Scotland, UK) was added and incubated for 30 min at RT, the reaction was stopped with 50 μl of sulphuric acid 1N and read at 450 nm with a VERSAmax microplate reader (BIO-TEK Synergy HT). IgG concentration was determined using a commercial mouse IgG standard curve.
Antibody efficiency in peptide recognition was also evaluated by ELISA. Briefly, multiwell plates were incubated ON at 4ºC with serial dilutions of the peptides (from 2 ng/μl). After blocking with 1% BSA in PBS for 2 hrs at 37ºC, they were incubated for 90 min at 37ºC with 40 ng/μl of the anti-epitope of caspase-3 and for 90 min with the second antibody-HRP, at a dilution of 1:7.000. After both incubation plates were washed, they were incubated with TMB and read as described above. As a control, we used another synthetic peptide which is not recognized by the anti-epitope of caspase-3. 
P. salmonis infection assays
Monolayers containing adherent macrophage-like RTS11 cells (Ganassin and Bols, 1998) were grown and infected as previously described (Rojas et al. 2009 ). Briefly, cells were seeded with L-15 medium supplemented with 15% fetal bovine serum (FBS) and then cultivated for 7 days to 80% confluence. Cells were washed with PBS and infected for 1 hr at 20ºC with P. salmonis at a multiplicity of infection (MOI) of 50. Cells were rinsed three times with PBS and incubated with fresh medium until 2 or 5 days post-infection.
ELISA and western blot
Monolayers containing adherent macrophage-like RTS11 cells were grown and infected as described above. Cells were lysed in buffer containing 20 mM Tris-HCl pH 8.0, 1 M NaCl, 0.05%Triton X-100, 3 mM phenylmethylsulphonylfluoride (PMSF), 5 mM EDTA, and 0.2% protease inhibitor cocktail (SigmaAldrich, MO, USA) and total proteins were measured by the bicinconinic acid method (BCA protein assay, Pierce, USA). For ELISA tests, 100 µl samples (15 ng/μl) were incubated overnight at 4ºC and the plates were washed three times with 200 µl of PBST 0.05% in JENCONS Millenium 1000 Automatic Microplate Washer. Samples were blocked with 1% BSA for 4 hrs at 37ºC and incubated with 40 ng/µl of the first antibody for 90 min at 37ºC. After washing, the second antibody, anti-mouse IgG-HRP (Thermo Scientific Inc., USA) at 1:20.000 was incubated for 60 min at 37ºC. 100 µl per well of TMB single solution (Invitrogen, Paisley, Scotland, UK) was added and incubated for 30 min at RT; the reaction was stopped with 50 µl of 1N sulfuric acid and read at 450 nm with a Molecular Devices (VERSAmax) microplate reader.
For western blotting, 30 μg of total proteins from non infected, P. salmonis infected and actinomycin induced cells were separated by 15% SDS/PAGE and transferred to a PVDF membrane previously activated in methanol for 5 min and washed in transfer buffer (20% methanol, 0.01% SDS, Tris 25 mM; glycine 192 mM). The gel sandwich was prepared in cassette and placed in the module following the manufacturer instruction's (Mini Trans-Blot BIORAD). The transfer was performed at 100 Volts for 90 min, the PDVF membrane was blocked overnight at 4ºC with 3% in PBSA and incubated with 100 ng/µl of the anti-epitope of caspase-3 for 90 min at 37ºC. After 5 washings, a second antibody at 1:8.000 conjugated to horseradish peroxidase was added for 60 min at 37ºC. The membrane was revealed by ECL western blotting (Pierce, USA) in Bio-Max film (Kodak).
Immunocytochemistry
Monolayers containing adherent macrophage-like RTS11 cells were grown onto poly-L-lysine coated coverslips (3.500 to 3.700 cells/coverslip). Infections were performed in triplicate using three independent wells, under conditions described above. Control non-infected, P. salmonis infected and macrophages treated for 30 hrs with 2 mg/ml of the apoptotic inducer actinomycin were evaluated for caspase-3 activation by indirect immunofluorescence (Rojas et al. 2009; Rojas et al. 2010) . Cells were fixed and permeabilized with cold methanol-acetic acid at 3:1 (v/v) for 15 min and washed three times in PBS. In order to detect caspase-3 the cells were incubated with 0.25 µg/µlof the caspase-3 anti-epitope and then with 1:100 (v/v) dilution of an antimouse secondary antibody conjugated to fluorescein isothiocyanate (FITC) (Sigma-Aldrich, MO, USA). In order to detect P. salmonis, cells were incubated with 1:500 (v/v) dilution of an anti-ChaPs proteinfrom the bacterium (Marshall et al. 2007 ) and subsequently labelled with 1:100 (v/v) of an antirabbit IgG Alexa Fluor 532-conjugated antibody (Molecular Probes). All incubations were done for 60 min at 20ºC in the dark and afterwards the incubation cells were washed three times with PBS. Cells were mounted with Vectashield mounting medium (Vector Labs., Inc., USA) and examined using a Leica Microsystems Confocal Scanning Laser microscope TCS SP5.
Statistical analyses
Caspase-3 activation in non-infected, infected and induced cells was analyzed using a one-way analysis of variance ANOVA. Differences were considered significant at a level of p < 0.05.
RESULTS
Peptide synthesis and identification
The in silico analysis of the caspase-3 primary sequences defined the peptide KTLVGKPKLFFIQACRG as the most flexible (average score near 0.5) and the less hydrophobic region (average score near 0). This peptide which included the conserved QACXG motif was chosen as the candidate epitope. The selected epitope was chemically synthesized and its high purity was confirmed by reverse-phase HPLC (RP-HPLC) (Figure 1a) . The molecular mass of the peptide was determined as 1906.6 by mass spectrometry Maldi-Tof where the value is consistent with the theoretical mass (Figure 1b) . In addition, to identify the secondary structure of the peptide, circular dichroism (CD) spectroscopy was used to reveal a peptide conformation with α-helix tendency (Figure 1c ).
Peptide validation
Anti-caspase-3 IgG were enriched by caprylic acid methods and purified by immunoaffinity, maintaining their capacity for peptide recognition. Antibody validation was first shown at the qualitative level by dot blot testing (Figure 2a ). Antibody efficiency in peptide recognition was evaluated with serial dilutions of the peptides (ng/ul) by the indirect ELISA methods (Figure 2b) . In order to validate antibody specificity and to reject cross reaction, other peptides were tested with the antibody for caspase-3 without positive recognition.
ELISA analysis
Programmed cell death through apoptotic pathways is characterized by caspase activation. The presence of active caspase-3 in macrophage-like RTS11 cells infected with P. salmonis was detected by indirect ELISA. A significant increase (p < 0.05) of caspase-3 active recognition was detected in P. salmonis-infected cells at 5 days post-infection and in actinomycin D treated cells with respect to noninfected control cells (Figure 3 ).
Western blot analysis of caspase-3 activation
The western blotting analysis shows the activation of caspase-3 in P. salmonis infected macrophagelike RTS11 (Figure 4b ). In non-infected cells the antibody recognized only the precursor form, which according to the number of amino acid residues described for trout caspase-3 (GenBank CBY85134) has an expected molecular mass of 31 kDa. In infected cells, it recognized both the pro-caspase and the processed forms; accordingly to cleavage sites in trout and salmon sequences, the large caspase-3 subunit has an expected molecular mass of 15 kDa (Figure 4a ) (Yabu et al. 2001) . The housekeeping protein used was salmonid Hsc 70 (Bethke et al. 2012) .
Contrarily, when evaluating commercial anti-caspase-3 antibodies made against both unprocessed (BD Pharmigen 552785 and Santa Cruz Biotechnology, Inc. sc-7148) and active (BD Pharmigen 551150) form of mammal caspase-3, they not recognized the enzyme in RTS11 cells.
In vitro evaluation
We confirmed apoptosis via the presence of active caspase-3 in situ in macrophage-like RTS11 cells infected for 2 and 5 days with P. salmonis ( Figure 5 ). Using immunocytochemistry, a positive reaction was clearly detected in infected cells but not in non-infected controls cells. Moreover, a significant increase in the number of positive macrophages to active caspase-3 was observed with the increase in days post-infection. Caspase-3 was also detected in macrophages treated with the apoptotic inductor actinomycin D. The localization of active caspase-3, with a punctuate pattern of distribution, was restricted to the cytoplasm and excluded completely from nuclei, as confirmed by confocal microscopy.
DISCUSSION
Apoptosis is a programmed cell death mechanism with the ordered dismantling of the cells showing characteristic morphologic and biochemical changes. This cell death process is evolutionarily conserved and some of its components have stayed through animal evolution, including in fish. In this case, a caspase-3 gene has been identified in zebrafish (Yabu et al. 2001; Chakraborty et al. 2006) and sea bass (Reis et al. 2007) , retaining the motifs that are functionally important, such as the active site and the cleavage site at the aspartic residue; nevertheless, phylogenetic analysis shows that fish corresponds to a divergent evolving group, hindering the detection of fish caspase through commercial antibodies developed against mammalian caspases. In order to solve this problem, we have developed an antibody that allows the detection of a salmonid caspase-3.
Apoptosis is part of pathogenesis of several infectious diseases. Different viruses, bacteria and protozoa have developed a survival strategy by activating the apoptotic death of immune cells, mainly macrophages, and so evading defense mechanisms (Gao and Kwaik, 2000; Gaddy and Lyles, 2005; Hong et al. 2005; Santi et al. 2005; Carrero and Unanue, 2006; Miyairi and Byrne, 2006; Rojas et al. 2010) . In this work we validated this antibody through different immunological assays using the caspase-3 activation in RTS11 apoptotic cells infected by P. salmonis as a model.
ELISA and western blotting analysis show active caspase-3 in P. salmonis infected cells. Molecular mass of precursor and subunits of trout caspase-3 are according with the amino acid residues and the cleavage sites described in GenBank. Moreover, molecular weights determined for pro-caspase and active caspase-3 in RTS11 infected cells are according with those predicted in zebrafish and sea bass. In the first species caspase-3 was cloned fused to a His tag sequence at the N-terminus, the western blotting using an anti-His-tag antibody reported the precursor form (31.5 kDa), and an active subunit of 13 kDa (Yabu et al. 2001; Chakraborty et al. 2006) . In sea bass, caspase-3 shows an ORF of 281 amino acid residues with a predicted molecular mass of 31.1 kDa; in this case, a human caspase-3 antibody can recognizes only the large subunit of the activated enzyme but not the precursor form (Reis et al. 2007 ). Moreover, caspase-3 induction was verified by immunocytochemistry assays, there was a time dependent increase in the active form of this enzyme, which co-localized with the bacterium.
Through this antibody we are contributing with an effective tool to better understand the mechanisms of cell death in trout, and to help identifying the involvement of apoptosis in a large number of different events such as embryogenesis, tissue homeostasis, disease development and response to different infective pathogens in this salmonid fish. Moreover, this antibody could be applied for caspase-3 detection in other fish species presenting identical or high homology in the epitope sequence, like salmon or zebrafish respectively; nevertheless, is required to have an established model of apoptosis for this species.
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